
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/">
  <dc:identifier>https://unilib.phaidrabg.rs/o:7490</dc:identifier>
  <dc:identifier>ISBN: 978-86-7520-629-3</dc:identifier>
  <dc:title xml:lang="eng">BENEFICIAL IMPACTS OF CHOKEBERRY AND TART CHERRY BASED DIETARY SUPPLEMENTS IN DIABETICS</dc:title>
  <dc:date>2025</dc:date>
  <dc:description xml:lang="eng">Diabetes mellitus (DM) is a metabolic disorder that may cause increased risk of various diseases mostly
cardiovascular ones. Currently, available therapies are effective for some individuals, but not all. As a result,
there is a high need for novel antidiabetic medications or treatments which can help to regulate glycemia or
reduce the negative consequences of diabetes, especially on blood vessels. Epidemiological studies have shown
that diet can significantly affect blood sugar levels, and berries rich in polyphenols, especially anthocyanins,
have shown particularly good effects. Concerning the chemical composition of chokeberry (Aronia
melanocarpa), it has been highlighted that anthocyanins are the most important pharmacologically active
compounds responsible for its antioxidative, anti-inflammatory, and vasoprotective effects. More recently, the
promising potential of cherry juice, originated from tart cherry (Prunus cerasus), a low-calorie fruit rich in
secondary metabolites such as anthocyanins, hydoxycinnamates, and flavan-3-ols, in terms of its antioxidant
(stimulation of superoxide dismutase and glutathione peroxidase) and anti-inflammatory properties (inhibition of
cyclooxygenase-2) was revealed Our aim was to evaluate the effect of combined oral consumption of two
dietary supplements based on chokeberry and tart cherry juices over a period of 90 days on HbA1C and, systolic
and diastolic pressure, intimo-medial complex (IMC) where atherosclerosis takes place and safety in 27
volunteers with diabetes type 2. Moreover, in vitro antidiabetic activity of juices and supplements were studied.
Statistically significant decrease in the thickness of both, carotid and femoral artery was noticed. Slight decrease
in systolic and diastolic pressure was observed but it was not statistically significant while an improvement in
HbA1C was observed in 62% of respondents. Moreover, the levels of creatinine, urea, ALT and AST values
remained within normal limits, which indicates that the products did not have negative effects on the liver and
kidneys during the study pointed its safety. In vitro inhibition of both, alpha-glucosidase and alpha-amylase was
noticed for chokeberry and tart cherry juices as well as for both dietary supplements (IC50 0.11 ± 0.02, 21.77 ±
1.66, 0.06 ± 0.01, 0.08 ± 0.01, 5.13 ± 0.11, 12.51 ± 0.83, 6.89 ± 0.36, 9.28 ± 0.04 mg/mL, respectively).</dc:description>
  <dc:source>BOOK OF ABSTRACTS</dc:source>
  <dc:source>startpage: 32</dc:source>
  <dc:source>endpage: 33</dc:source>
  <dc:language>eng</dc:language>
  <dc:subject xml:lang="eng">chokeberry, tart cherry, dietary supplements, diabetes</dc:subject>
  <dc:type>info:eu-repo/semantics/conferenceProceedings</dc:type>
  <dc:format>application/pdf</dc:format>
  <dc:format>1190914 bytes</dc:format>
  <dc:creator id="https://orcid.org/0000-0002-2086-9593">Šavikin, Katarina</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-9684-2637">Živković, Jelena</dc:creator>
  <dc:creator id="https://orcid.org/0000-0003-3611-9911">Krgović, Nemanja</dc:creator>
  <dc:creator id="https://orcid.org/0000-0003-1999-2743">Bigović, Dubravka</dc:creator>
  <dc:rights>All rights reserved</dc:rights>
</oai_dc:dc>
